NCT02952482View on ClinicalTrials.gov

Newborn Screening for Adrenoleukodystrophy

CompletedOBSERVATIONAL
Enrollment

45,796

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Adrenoleukodystrophy
Interventions
PROCEDURE

newborns testing for ALD

Routine newborn screening dried blood spots sample is used to test if elevation of C26:0-lyso-PC

Trial Locations (1)

100

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT02952482 - Newborn Screening for Adrenoleukodystrophy | Biotech Hunter | Biotech Hunter